Eur Heart J:欧洲动脉粥样硬化学会:家族性高胆固醇血症的诊治及靶标

2013-08-29 高晓方 译 cmt

近日,欧洲动脉粥样硬化学会(EAS)发表文章指出,普通人群的家族性高胆固醇血症(FH)的诊断和治疗率均较低,为此,EAS发表了FH预防冠心病的诊治指南与共识,相关文章8月15日在线发表于《欧洲心脏杂志》(Eur Heart J)。【原文下载】 指南指出,依据杂合子FH的理论估计1/500患病率,在大多数国家中FH诊断率低于1%。近期北欧普通人群直接筛查得出的杂合子FH患病



近日,欧洲动脉粥样硬化学会(EAS)发表文章指出,普通人群的家族性高胆固醇血症(FH)的诊断和治疗率均较低,为此,EAS发表了FH预防冠心病的诊治指南与共识,相关文章8月15日在线发表于《欧洲心脏杂志》(Eur Heart J)。【原文下载

指南指出,依据杂合子FH的理论估计1/500患病率,在大多数国家中FH诊断率低于1%。近期北欧普通人群直接筛查得出的杂合子FH患病率约为1/200。所有研究均显示,相当高比例的FH患者未能实现推荐LDL胆固醇靶目标,并且冠心病风险最高增加13倍。基于1/500和1/200的患病率,全球FH患者介于1400至3400万之间。



如果个人或家庭成员伴有FH、成人血浆胆固醇水平≥8 mmol/L(≥310 mg/dL)或儿童≥6 mmol/L(≥230 mg/dL)、早发冠心病、腱黄瘤或早发心源性猝死,则推荐儿童、成人和家庭成员进行FH筛查。在FH患者中,儿童低密度脂蛋白胆固醇靶目标为<3.5 mmol/L(<135 mg/dL),成人<2.5 mmol/L(<100 mg/dL),伴冠心病或糖尿病患者则为<1.8 mmol/L(<70 mg/dL)。

除生活方式和膳食咨询外,儿童优选治疗包括他汀类、依折麦布和胆酸结合树脂,成人则包括最有效剂量他汀类、依折麦布和胆酸结合树脂。对于纯合子FH和治疗抵抗且伴冠心病FH,可进行脂蛋白血浆清除治疗。由于FH诊断和治疗严重不足,目前迫切需要在全球范围内对此种极高危疾病进行诊断性筛查和早期积极治疗。

原始出处:

Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Kees Hovingh G, Kovanen PT, Boileau C, Averna M, Borén J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR, Tybjærg-Hansen A; for the European Atherosclerosis Society Consensus Panel.Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society.Eur Heart J. 2013 Aug 15. 【原文下载

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1944353, encodeId=01e51944353fb, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jun 14 21:26:00 CST 2014, time=2014-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338897, encodeId=551b133889e05, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352713, encodeId=e7f11352e131d, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99963, encryptionId=827d9996311, topicName=靶标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355794, encodeId=73ab1355e9452, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380010, encodeId=a3951380010fe, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102602, encryptionId=bef6102602a9, topicName=高胆固醇血症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1d1470, createdName=刘阔, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562191, encodeId=18421562191be, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629461, encodeId=d4c416294615e, content=<a href='/topic/show?id=c61d4641821' target=_blank style='color:#2F92EE;'>#家族性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46418, encryptionId=c61d4641821, topicName=家族性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc21339997, createdName=wetgdt, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1944353, encodeId=01e51944353fb, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jun 14 21:26:00 CST 2014, time=2014-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338897, encodeId=551b133889e05, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352713, encodeId=e7f11352e131d, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99963, encryptionId=827d9996311, topicName=靶标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355794, encodeId=73ab1355e9452, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380010, encodeId=a3951380010fe, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102602, encryptionId=bef6102602a9, topicName=高胆固醇血症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1d1470, createdName=刘阔, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562191, encodeId=18421562191be, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629461, encodeId=d4c416294615e, content=<a href='/topic/show?id=c61d4641821' target=_blank style='color:#2F92EE;'>#家族性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46418, encryptionId=c61d4641821, topicName=家族性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc21339997, createdName=wetgdt, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1944353, encodeId=01e51944353fb, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jun 14 21:26:00 CST 2014, time=2014-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338897, encodeId=551b133889e05, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352713, encodeId=e7f11352e131d, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99963, encryptionId=827d9996311, topicName=靶标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355794, encodeId=73ab1355e9452, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380010, encodeId=a3951380010fe, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102602, encryptionId=bef6102602a9, topicName=高胆固醇血症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1d1470, createdName=刘阔, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562191, encodeId=18421562191be, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629461, encodeId=d4c416294615e, content=<a href='/topic/show?id=c61d4641821' target=_blank style='color:#2F92EE;'>#家族性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46418, encryptionId=c61d4641821, topicName=家族性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc21339997, createdName=wetgdt, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
    2013-08-31 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=1944353, encodeId=01e51944353fb, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jun 14 21:26:00 CST 2014, time=2014-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338897, encodeId=551b133889e05, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352713, encodeId=e7f11352e131d, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99963, encryptionId=827d9996311, topicName=靶标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355794, encodeId=73ab1355e9452, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380010, encodeId=a3951380010fe, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102602, encryptionId=bef6102602a9, topicName=高胆固醇血症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1d1470, createdName=刘阔, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562191, encodeId=18421562191be, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629461, encodeId=d4c416294615e, content=<a href='/topic/show?id=c61d4641821' target=_blank style='color:#2F92EE;'>#家族性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46418, encryptionId=c61d4641821, topicName=家族性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc21339997, createdName=wetgdt, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
    2013-08-31 zhaojie88
  5. [GetPortalCommentsPageByObjectIdResponse(id=1944353, encodeId=01e51944353fb, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jun 14 21:26:00 CST 2014, time=2014-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338897, encodeId=551b133889e05, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352713, encodeId=e7f11352e131d, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99963, encryptionId=827d9996311, topicName=靶标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355794, encodeId=73ab1355e9452, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380010, encodeId=a3951380010fe, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102602, encryptionId=bef6102602a9, topicName=高胆固醇血症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1d1470, createdName=刘阔, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562191, encodeId=18421562191be, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629461, encodeId=d4c416294615e, content=<a href='/topic/show?id=c61d4641821' target=_blank style='color:#2F92EE;'>#家族性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46418, encryptionId=c61d4641821, topicName=家族性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc21339997, createdName=wetgdt, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1944353, encodeId=01e51944353fb, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jun 14 21:26:00 CST 2014, time=2014-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338897, encodeId=551b133889e05, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352713, encodeId=e7f11352e131d, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99963, encryptionId=827d9996311, topicName=靶标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355794, encodeId=73ab1355e9452, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380010, encodeId=a3951380010fe, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102602, encryptionId=bef6102602a9, topicName=高胆固醇血症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1d1470, createdName=刘阔, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562191, encodeId=18421562191be, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629461, encodeId=d4c416294615e, content=<a href='/topic/show?id=c61d4641821' target=_blank style='color:#2F92EE;'>#家族性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46418, encryptionId=c61d4641821, topicName=家族性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc21339997, createdName=wetgdt, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
    2013-08-31 slcumt
  7. [GetPortalCommentsPageByObjectIdResponse(id=1944353, encodeId=01e51944353fb, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Jun 14 21:26:00 CST 2014, time=2014-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338897, encodeId=551b133889e05, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1352713, encodeId=e7f11352e131d, content=<a href='/topic/show?id=827d9996311' target=_blank style='color:#2F92EE;'>#靶标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99963, encryptionId=827d9996311, topicName=靶标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355794, encodeId=73ab1355e9452, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1380010, encodeId=a3951380010fe, content=<a href='/topic/show?id=bef6102602a9' target=_blank style='color:#2F92EE;'>#高胆固醇血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102602, encryptionId=bef6102602a9, topicName=高胆固醇血症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1d1470, createdName=刘阔, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562191, encodeId=18421562191be, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629461, encodeId=d4c416294615e, content=<a href='/topic/show?id=c61d4641821' target=_blank style='color:#2F92EE;'>#家族性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46418, encryptionId=c61d4641821, topicName=家族性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26fc21339997, createdName=wetgdt, createdTime=Sat Aug 31 05:26:00 CST 2013, time=2013-08-31, status=1, ipAttribution=)]
    2013-08-31 wetgdt

相关资讯

LANCET:PCSK单克隆抗体降低家族性高胆固醇血症患者的低密度脂蛋白胆固醇试验

  背景  1期试验结果显示,抑制蛋白质原转换酶枯草杆菌蛋白酶/kexin 9型丝氨酸蛋白酶(PCSK9)可使低密度脂蛋白胆固醇(LDL-C)水平大幅降低。本研究评价了在他汀类药物的基础上加用PCSK9单克隆抗体REGN727,其不同剂量和给药间隔进一步降低杂合型家族性高胆固醇血症患者LDL-C的有效性和安全性。   方法  这项多中心、随机、安慰剂对照2期试验在美国和加拿大

Lancet:新药Lomitapide有助治疗家族性高胆固醇血症

  11月2日,《柳叶刀》(Lancet)杂志在线发表了一项微粒体甘油三酯转移蛋白抑制剂Lomitapide治疗纯合子家族性高胆固醇血症(HoFH)的研究,结果表明,Lomitapide对于治疗HoFH有重要价值。   该研究为一项单盲、开放标签、临床Ⅲ期研究,HoFH患者从基线前6周开始当前的降脂治疗,并至少维持至第26周。Lomitapide的剂量根据安全性和耐受性逐渐从每天5 m

Heart:多种策略确定家族性高胆固醇血症

  英国学者的一项研究表明,伴有腱黄色瘤(TX)的确定性家族性高胆固醇血症(FH)患者应行基因分型。在可疑性FH患者中,冠心病病史或粥样斑块影像学证据是确认可能伴有单基因FH患者的最佳方法。论文于2012年12月4日在线发表于《心脏》(Heart)杂志。   此项研究共纳入204例年龄为(55±14)岁的患者,其中36%伴有TX,21%伴有冠心病[低密度脂蛋白胆固醇(LDL-C)为(6.20±2